•  
  •  
  •  
  •  

2025-10-10 10:50:54

  • Home
  • Commodities
  • Industry News
  • IPO
  • Mutual Funds
  • Others
  • Research
  • Watch List
Latest News
  • 5paisa Capital Ltd posts consolidated net profit of Rs. 9.48 crores in Q2 FY2026
  • Tata Elxsi Ltd Q2 FY2025-26 consolidated net profit up QoQ at Rs. 154.81 crores
  • Tata Consultancy Services Ltd posts consolidated Q2FY26 PAT of Rs. 12075 crores
  • Eimco Elecon India Ltd Q2 FY2026 net profit slides to Rs. 5.35 crores
  • GM Breweries Ltd Q2FY26 PAT jumps to Rs. 34.89 crores

Keywords Selected:  INE475E01026

Stock Report

  • Caplin Steriles Ltd granted final approval for ANDA Milrinone Lactate in 5% Dextrose Injection by USFDA
  • Caplin Point Laboratories Limited declares interim dividend of Rs. 3
  • Caplin Steriles Ltd receives USFDA final approval for ANDA Haloperidol Decanoate Injection
  • Caplin Steriles Ltd gets USFDA approval for Phytonadione Injectable Emulsion
  • Caplin Steriles Ltd receives USFDA final approval for ANDA Brimonidine Tartrate and Timolol Maleate Ophthalmic Solution
  • Caplin Steriles gets USFDA approval for Levetiracetam in Sodium Chloride Injection, Infusion Bags
  • Caplin Steriles gets USFDA approval for Difluprednate Ophthalmic Emulsion
  • ANVISA - Brazil completes inspection at Caplin Steriles' facility at Gummidipoondi
  • Caplin Steriles Ltd gets USFDA approval for Ephedrine Sulfate injection USP
  • Caplin Point gets Colombia approval for Softgel Capsules
  • Caplin Steriles gets USFDA approval for Ofloxacin Ophthalmic Solution
  • Caplin Steriles gets USFDA approval for Ketorolac Tromethamine Ophthalmic Solution
  • Caplin Group successfully completes new Oncology facility, commences operations
  • Caplin Group announces Strategic Investment of INR 700 Crores in Tamil Nadu
  • Caplin Steriles Ltd gets USFDA approval for Ofloxacin OTIC Solution
  • Caplin Steriles gets USFDA approval for Norepinephrine Bitartrate Injection
  • Caplin Steriles receives EIR from US FDA
  • Caplin Point listed on Forbes Asia's '200 Best Under a Billion' for 2023
  • Caplin Steriles Ltd receives final approval from USFDA for ANDA Cisatracurium Besylate Injection USP
  • US FDA inspection completed at Caplin Steriles Injectable site at Gummidipoondi
  • Caplin Steriles gets USFDA approval for Ketorolac Tromethamine Injection
  • Caplin Steriles Ltd granted final approval by USFDA for Thiamine Hydrochloride Injection ANDA
  • Caplin Steriles Ltd granted final approval from USFDA for ANDA Rocuronium Bromide Injection
  • Caplin Point listed on Forbes Asia's '200 Best Under a Billion' for 2022

Latest Post

  • 5paisa Capital Ltd posts consolidated net profit of Rs. 9.48 crores in Q2 FY2026
  • Tata Elxsi Ltd Q2 FY2025-26 consolidated net profit up QoQ at Rs. 154.81 crores
  • Tata Consultancy Services Ltd posts consolidated Q2FY26 PAT of Rs. 12075 crores
  • Eimco Elecon India Ltd Q2 FY2026 net profit slides to Rs. 5.35 crores
  • GM Breweries Ltd Q2FY26 PAT jumps to Rs. 34.89 crores


Announcement

To Advertise in our website please e-mail us at advertisement@equitybulls.com
Companies can send their Press Releases to pressrelease@equitybulls.com

Links

  • Home
  • Contact
  • Our Team

Contact

The website is developed and maintained by Chennai Scripts
C-4, Podhigai Flats, Pillayar Koil Street, Nesapakkam
Chennai
Tamil Nadu
India
600078
E-mail: chennaiscripts@gmail.com
Mobile Phone Number: +91-88776-69935
www.chennaiscripts.com

Website Created & Maintained by : Chennai Scripts
Nesapakkam, Chennai - 600 078,
Tamil Nadu, India

Disclaimer Copyright © - 2024